Your account is not claimed yet. You can sign up with ORCID to claim your account.

Taranjit S Gujral (Taran S Gujral)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Venues

bioRxiv : the preprint server for biology

Molecular cancer research : MCR

Oncoimmunology

Proceedings of the National Academy of Sciences of the United States of America

Fred Huthinson Cancer Research Center

Queen's University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fred Huthinson Cancer Research Center

United States

Assistant Member :: Human Biology

Education History

Queen's University Sep 1o 2005 - Oct 30o 2008

Canada

PHD :: Pathology & Molecular Medicine

Publications

Annabel T Olson, Yuqi Kang, Anushka M Ladha, Chuan Bian Lim, Michael Lagunoff, Taranjit S Gujral, Adam P Geballe
Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. bioRxiv : the preprint server for biology (2023)
Annabel T Olson, Yuqi Kang, Anushka M Ladha, Chuan Bian Lim, Michael Lagunoff, Taranjit S Gujral, Adam P Geballe
Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. bioRxiv : the preprint server for biology (2023)
Annabel T Olson, Yuqi Kang, Anushka M Ladha, Chuan Bian Lim, Michael Lagunoff, Taranjit S Gujral, Adam P Geballe
Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. bioRxiv : the preprint server for biology (2023)
Frank Szulzewsky, Sonali Arora, Aleena K S Arakaki, Philipp Sievers, Damian A Almiron Bonnin, Patrick J Paddison, Felix Sahm, Patrick J Cimino, Taranjit S Gujral, Eric C Holland
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. Genes & development (2022)
Marina Chan, Eric C Holland, Taranjit S Gujral
Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells. EMBO molecular medicine 14 (6) (2022)
Federica Mossa, Daniele Robesti, Ramachandran Sumankalai, Eva Corey, Mark Titus, Yuqi Kang, Jianhua Zhang, Alberto Briganti, Francesco Montorsi, Christopher P Vellano, Joseph R Marszalek, Daniel E Frigo, Christopher L Logothetis, Taranjit S Gujral, Eleonora Dondossola
Subtype and site specific-induced metabolic vulnerabilities in prostate cancer. Molecular cancer research : MCR (2022)
Caroline Xue, Eva Corey, Taranjit S Gujral
Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors. Cancers 14 (7) (2022)
Kevin M Sullivan, Xiuyun Jiang, Prajna Guha, Christopher Lausted, Jason A Carter, Cynthia Hsu, Kevin P Labadie, Karan Kohli, Heidi L Kenerson, Sara K Daniel, Xiaowei Yan, Changting Meng, Arezou Abbasi, Marina Chan, Y David Seo, James O Park, Ian Nicholas Crispe, Raymond S Yeung, Teresa S Kim, Taranjit S Gujral, Qiang Tian, Steven C Katz, Venu G Pillarisetty
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut (2022)
Nao Nishida-Aoki, Taranjit S Gujral
Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype. Cancer research 82 (3) (2021)
Marina Chan, Siddharth Vijay, John P McNevin, M Juliana McElrath, Eric C Holland, Taranjit S Gujral
Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release. Molecular systems biology 17 (9) (2021)
Thomas Bello, Claudia Paindelli, Luis A Diaz-Gomez, Anthony Melchiorri, Antonios G Mikos, Peter S Nelson, Eleonora Dondossola, Taranjit S Gujral
Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (40) (2021)
Ramya Sivakumar, Marina Chan, Jiye Stella Shin, Nao Nishida-Aoki, Heidi L Kenerson, Olivier Elemento, Himisha Beltran, Raymond Yeung, Taranjit S Gujral
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery. Oncoimmunology 8 (12) (2019)

Taranjit S Gujral.css-eqlu8i{font-size:small;padding-left:4px;} (Taran S Gujral)

Publication Activity (10 Years)

Top Topics

Top Venues

Taranjit S Gujral (Taran S Gujral)